Table 1.
Impact of pharmacologic strategies on the occurrence of contrast-associated acute kidney injury.
Beneficial | May be beneficial | Inconsistent data | No benefit | May be harmful |
---|---|---|---|---|
Isotonic saline | Prostaglandin E1 Trimetazidine |
Nicorandil Alprostadil Alpha-tocopherol Angiotensin converting enzyme inhibitor / angiotensin II receptor blockers Calcium channel blockers Theophylline Ascorbic acid Statins N-acetylcysteine |
Dopamine Fenoldopam Atrial natriuretic peptide |
Mannitol Furosemide |